10 February 2026
Strong commercial performance and excellent pipeline delivery in a continuing catalyst-rich period Revenue and EPS summary FY 2025 % Change Q4 2025 …
GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older GSK plc (LSE/NYSE: GSK) today announced that…
9 February 2026
Wynnstay Group plc (“Wynnstay” or “the Group” or “the Company”) Agricultural supplies and services group Final Results for the year ended 31 October 2025…
6 February 2026
HgCAPITAL TRUST PLC TRADING UPDATE FOR THE YEAR ENDED 31 DECEMBER 2025 ESTIMATED NAV PERFORMANCE DRIVEN BY RESILIENT TRADING IN THE UNDERLYING PORTFOLIO IN…
Nucala (mepolizumab) approved by the European Commission for the treatment of chronic obstructive pulmonary disease (COPD) GSK plc (LSE/NYSE: GSK) today announced the European Commission…
SEATTLE–(BUSINESS WIRE)– Amazon.com, Inc. (NASDAQ: AMZN) today announced financial results for its fourth quarter ended December 31, 2025. Fourth Quarter 2025 Full Year 2025 “AWS…
MOUNTAIN VIEW, Calif. – February 4, 2026 – Alphabet Inc. (NASDAQ: GOOG, GOOGL) today announced financial results for the quarter ended December 31, 2025….
Full-Year Highlights Fourth-Quarter Highlights 2026 Guidance Woking, UK, February 5, 2026 – Linde plc (Nasdaq: LIN) today reported fourth-quarter 2025 net income of $1,530…